Dental Bone Graft Substitutes Market in terms of revenue was estimated to be worth $1.3 billion in 2024 and is poised to reach $1.8 billion by 2029, growing at a CAGR of 7.7% from 2024 to 2029 ...

Amphix Bio has received a breakthrough device designation from the US Food and Drug Administration (FDA) for its drug-device combination product aimed at bone regeneration. This designation ...

The Mayo Clinic's Lichun Lu is developing an expandable, biodegradable graft that could someday help metastatic spinal tumor patients recover from bone removal surgery. To replace the removed bone ...

Contacts. For further information: Locate Bio Limited John von Benecke, CEO +44 (0)115 784 0041 jvonbenecke@locatebio.com Media enquiries FTI Consulting Ciara Martin, Tim Stamper +44 (0) 203 727 ...

Researchers at the University of Iowa have created a bio patch containing DNA that delivers bone-producing instructions to cells. The bio patch contains a collagen platform embedded with the ...

ROURKELA: Researchers of the biotechnology and medical engineering wing of the National Institute of Technology-Rourkela (NIT-R) have developed a novel bio-ink for 3D bio-printing which can ...

Omni Bio Pharmaceutical, Inc. , a biopharmaceutical company focused on the commercialization of new uses of alpha-1 antitrypsin for the treatment of a variety of medical indications and the ...

CHARLESTON, S.C.--(BUSINESS WIRE)--Paradigm BioDevices, Inc. announces the launch of VisiCORE, a new bone graft harvesting system for foot and ankle fusion surgeries designed with a clear ...

There are many things weve come to expect from our computer printers: photos, letters, what have you. But muscle and bone? Scientists at Carnegie Mellon have developed a printer that outputs in b ...

Eggshell-derived amorphous calcium phosphate: Synthesis, characterization and bio-functions as bone graft materials in novel 3D osteoblastic spheroids model. COI Statement.

BioMimetic Therapeutics' Augment TM Bone Graft Receives Positive Recommendation from FDA Advisory Committee FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI), a ...